Navigation Links
Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized
Date:3/16/2011

ously ReportedRevisedTax benefit$

11,272$

15,037Net earnings$

7,959$

11,724Full Year 2010Previously ReportedRevisedTax benefit$

11,272$

15,037Net earnings$

6,888$

10,653About EndologixEndologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders.  The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement.  Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture.  The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.

Except for historical information contained herein, this news release contains forward-looking statements with respect to 2011 financial guidance, the accuracy of which are necessarily subject to risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond the control of Endologix. Many factors may cause actual results to differ materially from anticipated results, including the success of sales efforts for the Powerlink System and related new products, product research and development efforts, and other economic, business, competitive and regulatory factors. The Company undertakes no obligation to update its forward looking statements. Please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and the Company's other filings with the Securities and Exchange Commission, for more detailed information regarding these risks and other factors that may cause actual results to differ materially from those expres
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. Endologix Reports 30% Third Quarter 2010 Revenue Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Columbia , May 5, 2015  InMed ... clinical stage biopharmaceutical company that specializes in developing ... former GW Pharmaceuticals financier, investor, and Non-Executive Director, ... InMed as Strategic Advisor with primary responsibility for ... role, Mr. Mountford will leverage his previous success ...
(Date:5/4/2015)... VANCOUVER, British Columbia , May 4, ... announced today that it will report its first quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
(Date:5/4/2015)...  Amgen (NASDAQ: AMGN ) will present at the ... on Thursday, May 7, 2015, at the InterContinental in ... vice president of Global Commercial Operations at Amgen, will present ... accessed from the Events Calendar on Amgen,s website, www.amgen.com ... be available on Amgen,s website for 90 days following the ...
Breaking Medicine Technology:InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference 2
... 10, 2010 Mylan Inc. (Nasdaq: MYL ... conversion rate applicable to its 6.50% Mandatory Convertible Preferred ... common stock of the company effective as of November ... the governing provisions of the company,s Amended and Restated ...
... Pharmaxis, a global specialty pharmaceutical company focused on therapeutic ... (mannitol inhalation powder) Bronchial Challenge Test Kit, at the ... Asthma and Immunology (ACAAI), November 11-16 in Phoenix, AZ. ... Drug Administration (FDA) on October 5, 2010, ARIDOL is ...
Cached Medicine Technology:Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 2Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 3Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 4Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 5
(Date:5/4/2015)... (PRWEB) May 05, 2015 The ... Gloria M. Betancourt as a 2015-2016 inductee into ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... present Gloria with this important honor," said NAPW President ...
(Date:5/4/2015)... 2015 Every Friday afternoon at A ... in Southwest Michigan, patients and staff gather in the ... the rehabilitation program and to gain encouragement and inspiration ... , One by one, those patients who have completed ... their certificates and to share a bit about their ...
(Date:5/4/2015)... 2015 Global Vision, the industry ... today announced that it will showcase Proofware at ... Center, in Nashville Tennessee, May 04 and May ... true all-in-one we-based packaging inspection suite, giving enterprise-wide ... of their brand copy and artwork. Proofware offers ...
(Date:5/4/2015)... Leonardo J. Lozada, M.D., Saint Luke’s ... and William C. Daniel, M.D., Saint Luke’s Health System ... from the Secretary of the Air Force to attend ... Air War College, Maxwell Air Force Base, Alabama. The ... senior U.S. and international officers and their civilian counterparts ...
(Date:5/4/2015)... May 04, 2015 Milton Hershey School® ... 2015 Alumnus of the Year, recognizing his commitment to ... philanthropy he sets for MHS students. , “Dr. Graves ... happen when children are provided a top-notch education, a ... their passions,” said Pete Gurt ’85, president of MHS. ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2
... announced the approval of a new antifungal drug, for ... new drug called Eraxis, // is indicated in the ... ,The improved performance of Eraxis compared to ... have supported the approval. The drug can also be ...
... quite a trend setter of sorts. Now, BT Offices and ... // that smoking is banned in the BT premises as ... 26. Importantly, this move might encourage “anti-smoking” initiatives in other ... this announcement, which will surely set a precedent. Now this ...
... sex determination gene, that plays a crucial role in deciding ... (embryo with SRY gene develops into a male), could explain ... SRY protein, required for formation of testes is also produced ... Prince Henry's Institute and University of California. ,The ...
... infected by bird flu in northwestern Germany has been steadily ... // About 2 of the 103 cases were identified outside ... and troops have been involved in collection of carcasses. ... harbor the deadly virus. The Institute for Animal Health in ...
... reduce the harmful effects caused to babies by mothers who ... University. Foetal Alcohol Syndrome (FAS) results in mental retardation in ... ,The reserachers say that a drug called nicotinamide ... particular syndrome. The researchers arrived at this conclusion after successful ...
... foundation stone to construct a world-class cancer hospital and research ... at Rajarhat,// at the cost of Rs. 1.2 billion. ... would come up on a 10-acre plot, West Bengal Chief ... after laying the foundation stone for the project scheduled to ...
Cached Medicine News:Health News:Sex Determination Gene Blamed For High Incidence Of Parkinson’s In Me 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: